ATXI
PINK Avenue Therapeutics, Inc.$0.4005 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4005, $0.0485 below the day’s high of $0.4490
- YTD change
- -41.13%
- vs 20-day SMA
- -22.05%
- vs 200-day SMA
- -18.46%
Price ranges
Price & Performance
-0.05 (-10.34%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $13,882.3000
- ATXI is down 41% since the beginning of the year
- ATXI is down 44% over the past 12 months
- ATXI is down 23% over the past 1 month
- 0% of all ATXI investors are betting against ATXI
ATXI reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -43.6%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0485
- Last 5 days
- +0.11%
- vs 8-day SMA
- -3.69%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
